                </a></li></ul></div><p><strong>Figure 8.  <span>Suppressive effect of LY294002 on the <em>Pten</em>-deficient prostate enlargement.</span></strong></p><a id="article1.body1.sec2.sec4.fig1.caption1.p1" name="article1.body1.sec2.sec4.fig1.caption1.p1"></a><p>(A) The bar graph represented the relative weight (mean) of the anterior prostate lobe (AP weight in mg/body weight in g) of each group (n&gt; = 3). The <em>p</em> value was calculated by Student's <em>t</em>-test. Error bars represent the standard derivation. (B) Dissected anterior prostates of control (<em>Pten<sup>fx/fx</sup></em>) and of <em>R26-Pten<sup>fx/fx</sup></em> mice in the absence or presence of LY294002 for 4 weeks; these are shown as a gross view (upper panels) and with H&amp;E staining (middle panels). IHC of p-AKT(Ser473) is shown in the lower panels. Arrow indicates the focal positive for p-AKT in the LY294002-treated <em>R26-Pten<sup>fx/fx</sup></em> prostate.</p>
